Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways

Journal of Autoimmunity

Volumn 13, Issue 2, 1999, Pages 247-255

  Nervi, Solange ^a   Atlan Gepner, Catherine ^a   Fossat, Chantal ^b   Vialettes, Bernard ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

CD28; IDDM; Interleukin 2 system; T cell; TCR CD3 complex

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032859662     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0313     Document Type: Article

References (49)

1. Atkinson M.A., McLaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 24:1994;1428-1436.
2. Foulis A.K., McGill M., Farquharson M.A. Insulitis in type I (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes, and interferon-γ containing cells. J. Pathol. 165:1991;97-103.
3. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M.T., Ariza A., Gomis R., Bragado R., Marti M., Jaraquemada D., Pujol-Borrell R. Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J. Immunol. 153:1994;1360-1377.
4. Roep B. T-cell responses to autoantigens in IDDM. Diabetes. 45:1996;1147-1156.
5. Durinovic-Bello I., Hummel M., Ziegler A.G. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes. 45:1996;795-800.
6. Lampeter E.F., Homberg M., Quabeck K., Schaefer U.W., Wernet P., Bertrams J., Grosse-Wilde H., Gries F.A., Kolb H. Transfer of insulin-dependent diabetes between HLA-siblings by bone marrow transplantation. Lancet. 341:1993;1243-1244.
7. Vialettes B., Maraninchi D. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation [Letter]. Lancet. 342:1993;174.
8. Eliashiv A., Olumide F., Norton L., Eiseman B. Depression of cell-mediated immunity in diabetes. Arch. Surg. 113:1978;1180-1183.
9. Giordano C., Caruso C., Panto F., Modica M.A., Zambito A.M., Amato M.P., Galluzzo A. Dissociated production of interleukin-2 and immune gamma-interferon by phytohaemoagglutinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes. J. Clin. Lab. Immunol. 27:1988;73-76.
10. Giordano C., De Maria R., Todaro M., Mattina A., Richiusa P., Galluzzo G., Panto F., Galluzzo A. Study of T-cell activation in type I diabetic patients and pre-type 1 diabetic subjects by cytometric analysis: antigen expression defect in vitro. J. Clin. Immunol. 13:1993;68-78.
11. De Maria R., Todaro M., Stassi G., Di Blasi F., Giordano M., Galluzzo A., Giordano C. Defective T cell receptor/CD3 complex signaling in human type 1 diabetes. Eur. J. Immunol. 24:1994;999-1002.
12. Zier K.S., Leo M.M., Spielman R.S., Baker L. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes. 33:1984;552-555.
13. Kaye W.A., Adri M.N.S., Soeldner J.S., Rabinowe S.L., Kaldany A., Kahn C.R. Acquired defect in interleukin-2 production in patients with type 1 diabetes mellitus. N. Engl. J. Med. 315:1986;920-924.
14. Luger A., Schernthaner G., Urbanski A., Luger T.A. Cytokine production in patients with newly-diagnosed insulin-dependent (type 1) diabetes mellitus. Eur. J. Clin. Invest. 18:1988;233.
15. Giordano C., Panto F., Caruso C., Modica M.A., Zambito A.M., Sapienza N., Amato N.P. Interleukin-2 and soluble IL-2R secretion defect in vitro in newly diagnosed type 1 diabetic patients. Diabetes. 38:1989;310-315.
16. Tomoda T., Kurashige T., Taniguchi T. Imbalance of the interleukin 2 system in children with IDDM. Diabetologia. 37:1994;476-482.
17. Berman M.A., Sandborg C.I., Wang Z., Imfeld K.L., Zaldivar F., Dadufalza V., Buckingham B.A. Decreased IL-4 production in new onset type 1 insulin-dependent diabetes mellitus. J. Immunol. 157:1996;4690-4696.
18. Zipris D., Lazarus A.H., Crow A.R., Hadzija M., Delovitch T.L. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J. Immunol. 146:1991;3763-3771.
19. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:1993;87-99.
20. Serreze D.V., Leiter E.H. Defective activation of T suppressor cell function in non obese diabetic mice. J. Immunol. 140:1988;3801-3807.
21. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 7:1998;727-738.
22. Salojin K.V., Zhang J., Madrenas J., Delovitch T.L. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunol. Today. 19:1998;468-473.
23. Atlan-Gepner C., Hermitte L., Janand-Delenne B., Naquet P., Vialettes B. Different Th2-Th1 balance in Vβ8 and Vβ6 subsets of splenocytes in NOD females in the early phase of diabetogenesis. Diabetes Metab. 23:1997;386-394.
24. Rudd C.E. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity. 4:1996;527-534.
25. Lenschow D.J., Herold K.C., Rhee L., Patel B., Koons A., Qin H.Y., Fuchs E., Singh B., Thompson C.B., Bluestone J.A. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:1996;285-293.
26. Bonifacio E., Boitard C., Gleichmann H., Shattock M.A., Molenaar J.L., Bottazzo G.F. Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia. 33:1990;731-736.
27. Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E. Identification of protein tyrosine phospharase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155:1995;5419-5426.
28. Sasazuki T., Kimura A. XIth International HLA workshop on DNA components. 1991;Oxford University Press, Oxford.
29. Honeyman M.C., Stone N., de Aizpurua H., Rowley M.J., Harrison L.C. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. J. Autoimmun. 10:1997;165-173.
30. Gill B.M., Jaramillo A., Ma L., Laupland K.B., Delovitch T.L. Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mouse. Diabetes. 44:1995;614-619.
31. Garchon H.J. Non-MHC-linked genes in autoimmune diseases. Curr. Opin. Immunol. 4:1992;716-722.
32. Vyse T.J., Todd J.A. Genetic analysis of autoimmune disease. Cell. 85:1996;311-318.
33. Durinovic-Bello I., Steinle A., Ziegler A.G., Schendel D.J. HLA-DQ-restricted, islet-specific T-cell clones of a type 1 diabetic patient. Diabetes. 43:1994;1318-1325.
34. Conrad B., Weissmahr R.N., Böni J., Arcari R., Schüpbach J., Mach B. A human retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell. 90:1997;303-313.
35. Cooke A. Is there restricted T-cell receptor usage in autoimmune disease. Clin. Exp. Immunol. 83:1991;345-346.
36. Simone E., Daniel D., Schloot N., Gottlieb P., Babu S., Wegmann D., Eisenbarth G.S. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc. Natl. Acad. Sci. U S A. 94:1997;2518-2521.
37. Kontiainen S., Toomath R., Lowder J., Feldmann M. Selective activation of T cells in newly-diagnosed insulin-dependent diabetic patients: evidence for heterogeneity of T cell receptor usage. Clin. Exp. Immunol. 83:1991;347-351.
38. Edouard P., Thivolet C., Bedossa P., Olivi M., Legrand B., Bendelac A., Bach J.F., Camaud C. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice. Eur. J. Immunol. 23:1993;727-733.
39. Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mallitus. J. Clin. Invest. 90:1992;1901-1910.
40. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today. 12:1991;349-352.
41. Chambers C.A., Allison J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:1997;396-404.
42. Ward S.G., June C.H., Olive D. PI3-kinase: a pivotal pathway in T-cell activation. Immunol. Today. 17:1996;187.
43. Allen M.E., Young S.P., Michell R.H., Bacon P.A. Altered T lymphocyte signaling in rheumatoid arthritis. Eur. J. Immunol. 25:1995;1547-1554.
44. Garcia-Suarez J., Prieto A., Manzano L., Reyes E., Molto L., Alvarez-Mon M. T lymphocytes from autoimmune thrombocytopenic purpura show a defective activation and proliferation after cytoplasmic membrane and intracytoplasmic mitogenic signals. Am. J. Hematol. 44:1993;1-8.
45. Mueller D.L., Jenkins M.K. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7:1995;375-381.
46. Penninger J.M., Kromer G. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv. Immunol. 68:1998;51-144.
47. Giordano C., De Maria R., Stassi G., Todaro M., Richiusa P., Giordano M., Testi R., Galluzzo A. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM. Diabetologia. 38:1995;1449-1454.
48. Stassi G., Todaro M., De Maria R., Candore G., Cigna D., Caruso C., Galluzzo A., Giordano C. Defective expression of CD95 (Fas/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Hum. Immunol. 55:1997;39-45.
49. Van Parijs L., Abbas A.K. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:1996;355-361.